APIRA Pharmaceutical Company
(Private Equity)
(Private Equity)
INFINITIVE INNOVATION...
Innovative performance
Sustainable Excellence
Customer Orientation
Professional ethics
social responsibility
Teamwork
The development of knowledge-based
Value creating, Committed, Productive, Excellent
Which will be able to gain the maximum of market share for its products through supplying the most varied, updated and high quality products portfolio compared with competitors and to make Iran’s dependency to similar products import least; while it will be the first Iran’s half construct pharmaceutical products exporter to region markets and CIS countries.
APIRA pharmaceutical company wants to be able to have beneficial and constructive role as one of the most significant players completing the pharmaceutical supply chain in order to provide internal and external target market demands and improve the health level through producing and trading a variety portfolio of pharmaceutical products having distinguished quality and competitive price along with supplying knowledge-based and engineering services in its scope.
This company, while adhering to its core values, through the establishment of efficient and effective management systems, development of new and innovative products, development of domestic and foreign markets, continuous improvement of productivity and sustainable organizational excellence, application of knowledge and new technologies, development and empowerment of knowledge human capital As well as fulfilling environmental and social responsibilities, always strive to ensure the interests of all its stakeholders.
APIRA Pharma company infinitive innovation…
The idea of building the APIRA pharmaceutical factory in 2017 came to our mind from the country’s twenty-year roadmap to achieve maximum independence, especially in strategic industries such as drug supply.
To achieve our goal, we focused on less-targeted, knowledge-based sectors, which ensure profitable outcomes for our stockholders. In order to have better communication with countries in the geopolitical Middle East region, we decided to dedicate more than 7,000 square meters to the factory in the food and pharmaceutical section of the Industrial City of Kaveh Special Economic Zone.